Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh $52.68

down -1.06


22/8/2014 04:00 PM  |  NYSE : SNY  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get SNY Trend Analysis - it has underperformed the S&P 500 by 15%

Partner Headlines

  1. Illumina Joins Drugmakers To Make Cancer Test System

    IBD
  2. Illumina lines up key partners

    IBD
  3. Illumina Forms Partnerships With Big Pharma Firms

    IBD
  4. Stocks Open Higher, Turn Mixed; Illumina Rises, Autohome Slips

    IBD
  5. Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza

    GuruFocus
  6. Intermune up on buyout buzz

    IBD
  7. Benzinga's M&A Chatter for Wednesday August 13, 2014

    Benzinga
  8. Stocks Higher, Nasdaq Leads; Kinder Morgan, Priceline Rising

    IBD
  9. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  10. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga
  11. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  12. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  13. Len Schleifer's Science Focus Pays Off At Regeneron

    IBD
  14. UPDATE: Sanofi Posts Upbeat Q2 Earnings, Lifts Profit Outlook

    Benzinga
  15. Amgen Restructuring Plan, Q2 Earnings Send Stock Up

    IBD
  16. Sanofi

    IBD
  17. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  18. Stocks Recover Impressively; Gap Slumps In After Hours

    IBD
  19. Regeneron's Dupilumab Drug Headed For Phase Three Tests

    IBD
  20. Market Slides On European Bank Worries; Gold Stocks Rise

    IBD
  21. Benzinga's Top #PreMarket Gainers

    Benzinga
  22. UPDATE: Regeneron, Sanofi Offer Positive Results from Phase 2b Study of ...

    Benzinga
  23. Jazz, Novo Among Medicals Showing Healthy Action

    IBD
  24. Pharmas Soar To New Highs

    IBD
  25. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  26. Stocks Rise In Strong Turnover; Netflix Soars On Upgrade

    IBD
  27. Regeneron Rises As Sanofi Raises Stake In Biotech

    IBD
  28. Merrimack Pharmaceuticals Reaches Agreement With Sanofi, Regains Rights ...

    Benzinga
  29. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  30. Health Care Sector in an Upward Climb in June

    GuruFocus
  31. US Stock Futures Edge Higher Ahead Of Jobless Claims, Retail Sales Data

    Benzinga
  32. Top Held European Stocks Highlighted by Health Care and Oil and Gas Stocks

    GuruFocus
  33. Oakmark Funds' Bill Nygren Buys 4 New Stocks

    GuruFocus
  34. Eli Lilly insulin trial succeeds

    IBD
  35. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  36. Benzinga's Weekend M&A Chatter

    Benzinga
  37. Market Wrap For April 30: Markets Positive Despite Fed Tapering and GDP ...

    Benzinga
  38. Benzinga's M&A Chatter for Tuesday April 29, 2014

    Benzinga
  39. Bristol, Merck Q1 sales soft

    IBD
  40. Bristol, Merck, Sanofi Report Soft Q1 Sales

    IBD
  41. Allergan Reportedly Seeks Alternate Suitor

    FoxBusiness
  42. Week Ahead: April Jobs Report, FOMC Meeting and Earnings

    FoxBusiness
  43. Oakmark's Bill Nygren Discusses Financials, Favorite Stocks

    GuruFocus
  44. From Oakmark’s Market Beaters: Value + Income

    YCharts
  45. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  46. Cholesterol drug meets goal

    IBD
  47. Amgen Stock Gets Bump Up On Cholesterol Drug Data

    IBD
  48. New Cholesterol Fighters To Take Center Stage At ACC

    IBD
  49. US Stock Futures Rise; GDP, Jobless Claims Data In Focus

    Benzinga
  50. Sanofi's Getting Back in the Game

    GuruFocus
Trading Center